or
forgot password

    • cancer clinical trials in germantown, TN

    • A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers.
    The Jones Clinic
    Germantown, Tennessee 38138
    Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome, Systemic Mastocytosis
    Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
    C. Michael Jones, MD, PC
    Germantown, Tennessee 38138
    Chronic Lymphocytic Leukemia
    GW786034 In Subjects With Locally Recurrent Or Metastatic Clear Cell Renal Cell Carcinoma
    GSK Investigational Site
    Germantown, Tennessee 38138
    Solid Tumor Cancer, Renal Cell Carcinoma, Carcinoma, Renal Cell
    Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer
    GSK Investigational Site
    Germantown, Tennessee 38138
    Neoplasms, Breast
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Jones Clinic
    Germantown, Tennessee 38138
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Study To Assess Long Term Safety Of Pazopanib
    GSK Investigational Site
    Germantown, Tennessee 38138
    Cancer
    Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer
    The Jones Clinic, Pc
    Germantown, Tennessee 38138
    Non-small Cell Lung Cancer
    Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy
    GSK Investigational Site
    Germantown, Tennessee 38138
    Neoplasms, Prostate, Prostate Cancer
    GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
    GSK Investigational Site
    Germantown, Tennessee 38138
    Lung Cancer, Non-Small Cell
    ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
    GSK Investigational Site
    Germantown, Tennessee 38138
    Neoplasms, Breast, Breast Cancer
    Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC
    GSK Investigational Site
    Germantown, Tennessee 38138
    Neoplasms, Breast
    Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma
    GSK Investigational Site
    Germantown, Tennessee 38138
    Carcinoma, Renal Cell
    Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia
    GSK Investigational Site
    Germantown, Tennessee 38138
    WT1-positive Acute Myeloid Leukemia, Leukaemia, Myelocytic, Acute
    Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
    GSK Investigational Site
    Germantown, Tennessee 38138
    Solid Tumors, Neoplasms, Breast, Cancer
    Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC
    1199.14.1056 Boehringer Ingelheim Investigational Site
    Germantown, Tennessee
    Carcinoma, Non-Small-Cell Lung
    Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Pharmatech Oncology Study Site
    Germantown, Tennessee 38138
    Diffuse Large B-Cell Lymphoma
    A Phase I, Open-Label, First-Time-In-Human Study of the Oral AKT Inhibitor GSK2141795
    GSK Investigational Site
    Germantown, Tennessee 38138
    Cancer
    A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
    GSK Investigational Site
    Germantown, Tennessee 38138
    ErbB2 Overexpressing, Solid Tumors, Metastatic Breast Cancer, Neoplasms, Breast
    Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
    The Jones Clinic Dept .of The Jones Clinic (3)
    Germantown, Tennessee 38138
    HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer
    Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
    GSK Investigational Site
    Germantown, Tennessee 38138
    Leukaemia, Lymphocytic, Chronic
    A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma
    The Jones Clinic 7710 Wolf River Circle
    Germantown, Tennessee 38138
    Multiple Myeloma
    Investigate Safety, Pharmacokinetics and Pharmacodynamics of GSK2118436 & GSK1120212
    GSK Investigational Site
    Germantown, Tennessee 38138
    Cancer
    Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
    US Oncology - University of Tennessee Cancer Institute - Germantown
    Germantown, Tennessee 38138
    Chronic Lymphocytic Leukemia
    Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)
    The Jones Clinic
    Germantown, Tennessee 38138
    Non-small Cell Lung Cancer
    CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
    The Jones Clinic
    Germantown, Tennessee 38138
    Chronic Myelogenous Leukemia in Chronic Phase
    GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma
    GSK Investigational Site
    Germantown, Tennessee 38138
    Melanoma
    Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
    Gastro One
    Germantown, Tennessee 38138
    Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases, Colorectal Cancer
    A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain
    GSK Investigational Site
    Germantown, Tennessee 38138
    Melanoma and Brain Metastases
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    The Jones Clinic, Pc
    Germantown, Tennessee 38138
    Advanced Prostate Cancer, Prostatic Neoplasms
    An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer
    GSK Investigational Site
    Germantown, Tennessee 38138
    Lung Cancer, Non-Small Cell
    GSK1120212 Rollover Study
    GSK Investigational Site
    Germantown, Tennessee 38138
    Cancer
    Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim
    Sandoz Investigational Site
    Germantown, Tennessee 38138
    Chemotherapy-induced Neutropenia, Breast Cancer
    Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)
    GSK Investigational Site
    Germantown, Tennessee 38138
    Leukaemia, Lymphocytic, Chronic
    Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer
    For information concerning this clinical site, please contact Nymox at 800-936-9669.
    Germantown, Tennessee 38138
    Prostate Cancer
    Adenoviral Vector Monotherapy or Combination With Chemotherapy Study in Subjects With Recurrent/Metastatic Breast Cancer and Accessible/Visible Lesions
    The Jones Clinic
    Germantown, Tennessee 38138
    Recurrent/Metastatic Breast Cancer With Accessible Lesions
    Belimumab Assessment of Safety in SLE
    GSK Investigational Site
    Germantown, Tennessee 38138
    Systemic Lupus Erythematosus
    BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer
    GSK Investigational Site
    Germantown, Tennessee 38138
    Cancer